I said IMU didn't need the cash right now as evident by the quarterly just released and LC mentioned there will be further optimisation of funds.
How much CVI need to convert is dependent on the clinical trial updates, they've hedge whether there are further positive clinical trial update and paid a premium or poor so they don't need to do anything, that was the point of the CN for them.
LC mentioned they are "supporter" of IMU in her latest interview with Proactive so maybe they are looking to invest but like I said above, they've hedge so don't need to do anything.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)